SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-14-038337
Filing Date
2014-05-14
Accepted
2014-05-14 07:30:43
Documents
10
Period of Report
2014-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q a14-11323_110q.htm 10-Q 857041
2 EX-31.1 a14-11323_1ex31d1.htm EX-31.1 11725
3 EX-31.2 a14-11323_1ex31d2.htm EX-31.2 11574
4 EX-32 a14-11323_1ex32.htm EX-32 7891
  Complete submission text file 0001104659-14-038337.txt   5300657

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT nrx-20140331.xml EX-101.INS 616872
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT nrx-20140331.xsd EX-101.SCH 35167
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT nrx-20140331_cal.xml EX-101.CAL 30919
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT nrx-20140331_def.xml EX-101.DEF 200009
9 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT nrx-20140331_lab.xml EX-101.LAB 626755
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT nrx-20140331_pre.xml EX-101.PRE 299755
Mailing Address 79 T.W. ALEXANDER DRIVE 4401 RESEARCH COMMONS BLDG., SUITE 290 RESEARCH TRIANGLE PARK NC 27709
Business Address 79 T.W. ALEXANDER DRIVE 4401 RESEARCH COMMONS BLDG., SUITE 290 RESEARCH TRIANGLE PARK NC 27709 (609) 986-1780
NephroGenex, Inc. (Filer) CIK: 0001338095 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36303 | Film No.: 14839200
SIC: 2834 Pharmaceutical Preparations